{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:17:18Z","timestamp":1791389838031,"version":"4.3.3"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,18]]},"DOI":"10.1093\/cid\/cix791","type":"journal-article","created":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T07:10:04Z","timestamp":1504336204000},"page":"387-395","source":"Crossref","is-referenced-by-count":93,"title":["Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2\/3, Randomized, Single-Blind, Noninferiority, Controlled Study"],"prefix":"10.1093","volume":"66","author":[{"given":"Nithya J","family":"Gogtay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D H","family":"Ashwath Narayana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B J","family":"Mahendra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Kshirsagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagwat","family":"Gunale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Cheslock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saket","family":"Thaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Karande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipti","family":"Kumbhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H S","family":"Ravish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B R","family":"Harish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sambhaji S","family":"Pisal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Dhere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Parulekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C","family":"Blackwelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah C","family":"Molrine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad S","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,15]]},"reference":[{"key":"key\n\t\t\t\t20180118035150_CIT0001","volume-title":"WHO Expert consultation on rabies: second report. WHO Technical Report Series no 982","author":"World Health Organization","year":"2013"},{"key":"key\n\t\t\t\t20180118035150_CIT0002","doi-asserted-by":"crossref","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Global Alliance for Rabies Control Partners for Rabies Prevention","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20180118035150_CIT0003","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0264-410X(96)00314-3","article-title":"A global review of rabies vaccines for human use","volume":"15","year":"1997","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180118035150_CIT0004","first-page":"747","article-title":"Field trials with rabies vaccine on persons bitten by rabid wolves","volume":"13","year":"1955","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20180118035150_CIT0005","first-page":"773","article-title":"Laboratory data supporting the clinical trial of anti-rabies serum in persons bitten by a rabid wolf","volume":"13","year":"1955","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20180118035150_CIT0006","first-page":"168","article-title":"The use of antirabies gamma globulin in subjects severely bitten by rabid wolves or other animals","volume":"3","year":"1959","journal-title":"J Hyg Epidemiol Microbiol Immunol"},{"key":"key\n\t\t\t\t20180118035150_CIT0007","doi-asserted-by":"crossref","first-page":"S766","DOI":"10.1093\/clinids\/10.Supplement_4.S766","article-title":"Use of serum and vaccine in combination for prophylaxis following exposure to rabies","volume":"10","year":"1988","journal-title":"Rev Infect Dis"},{"key":"key\n\t\t\t\t20180118035150_CIT0008","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1016\/j.vaccine.2010.08.034","article-title":"Socioeconomic status is a critical risk factor for human rabies post-exposure prophylaxis","volume":"28","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180118035150_CIT0009","first-page":"459","article-title":"Demographics of animal bite victims & management practices in a tertiary care institute in Mumbai, Maharashtra, India","volume":"139","year":"2014","journal-title":"Indian J Med Res"},{"key":"key\n\t\t\t\t20180118035150_CIT0010","first-page":"32","article-title":"An epidemiological study of animal bites in India: results of a WHO sponsored national multi-centric rabies survey","volume":"38","year":"2006","journal-title":"J Commun Dis"},{"key":"key\n\t\t\t\t20180118035150_CIT0011","first-page":"375","article-title":"Elimination of human rabies in a canine endemic province in Thailand: five-year programme","volume":"81","year":"2003","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20180118035150_CIT0012","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.vaccine.2006.12.031","article-title":"Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates","volume":"25","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180118035150_CIT0013","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.antiviral.2011.06.002","article-title":"G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates","volume":"91","year":"2011","journal-title":"Antiviral Res"},{"key":"key\n\t\t\t\t20180118035150_CIT0014","unstructured":"Babcock\n              GJ\n            , LeaveBA, SloanSE. Fully human monoclonal antibody 17C7 neutralizes rabies virus endemic to Asia. In: Program and abstracts of the RITA XIX, International Conference on Rabies in the Americas, Atlanta, Georgia, 2008; page 54. https:\/\/drive.google.com\/file\/d\/0B3qyU7XS47AjYmJkODVhNDQtZjEwMi00Mzk1LWE2MjMtNDgxODMyMTI5NTM4\/view?hl=en&pref=2&pli=1."},{"key":"key\n\t\t\t\t20180118035150_CIT0015","unstructured":"Lumlertdacha\n              B\n            , SelfJ, HanlonC, SloanS, ThomasW, AmbrosinoD, RupprechtCE. Post-exposure prophylaxis (PEP) against Thai street rabies virus and Eurasian bat lyssaviruses with purified chick embryo vaccine, pepsin-digested ERIG, human rabies immune globulin and a human monoclonal antibody (MAB 17C7). In: Program and abstracts of the XVII International Conference on Rabies in the Americas, Brasilia, Brazil, 2006."},{"key":"key\n\t\t\t\t20180118035150_CIT0016","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.1016\/j.vaccine.2012.09.027","article-title":"Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: a randomized, dose-escalation phase 1 study in adults","volume":"30","author":"SII RMab author group","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180118035150_CIT0017","unstructured":"http:\/\/www.cdsco.nic.in\/writereaddata\/Office%20Order%20dated%2019.11.2013.pdf."},{"key":"key\n\t\t\t\t20180118035150_CIT0018","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.vaccine.2015.01.072","article-title":"Comparing vaccines: a systematic review of the use of the non-inferiority margin in vaccine trials","volume":"33","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180118035150_CIT0019","volume-title":"Guidelines on clinical evaluation of vaccines: regulatory expectations","author":"World Health Organization","year":"2004"},{"key":"key\n\t\t\t\t20180118035150_CIT0020","first-page":"693","article-title":"Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine","volume":"78","year":"2000","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20180118035150_CIT0021","first-page":"115","article-title":"C.1 Evaluation of new rabies vaccines for licensing C.1.1 General considerations for the clinical assessment of rabies vaccines","author":"World Health Organization","year":"2007"},{"key":"key\n\t\t\t\t20180118035150_CIT0022","first-page":"309","article-title":"Rabies vaccines: WHO Position Paper","volume":"85","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180118035150_CIT0023","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1016\/j.vaccine.2008.08.050","article-title":"First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity","volume":"26","year":"2008","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180118035150_CIT0024","unstructured":"Python\n              C\n            , QuiambaoB, MarissenW. Development of CL184 human monoclonal antibody cocktail for rabies post exposure prophylaxis: update on clinical evaluation. In: Program and abstracts of the RITA XIX International Conference on Rabies in the Americas, Atlanta, GA; 1 October 2008: 96\u20137. https:\/\/drive.google.com\/file\/d\/0B3qyU7XS47AjYmJkODVhNDQtZjEwMi00Mzk1LWE2MjMtNDgxODMyMTI5NTM4\/view?hl=en&pref=2&pli=1."},{"key":"key\n\t\t\t\t20180118035150_CIT0025","unstructured":"Quiambao\n              B\n            , BakkerA, BermalNN. Evaluation of the safety and neutralizing activity of CL184, a monoclonal antibody cocktail against rabies, in a phase II study in healthy adolescents and children. In: Program and abstracts of the RITA 1XX Rabies in the Americas, Quebec, Canada, 20 October 2009: \u201342\u20133. https:\/\/drive.google.com\/file\/d\/0B3qyU7XS47AjZjYyMWI5NWQtNzNjZi00ZTU2LTkxOWUtYmZlZmUzN2M4YzUw\/view?hl=en&pref=2&pli=1."},{"key":"key\n\t\t\t\t20180118035150_CIT0026"},{"key":"key\n\t\t\t\t20180118035150_CIT0027","doi-asserted-by":"crossref","first-page":"407","DOI":"10.15252\/emmm.201505986","article-title":"Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis","volume":"8","year":"2016","journal-title":"EMBO Mol Med"},{"key":"key\n\t\t\t\t20180118035150_CIT0028","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0001-706X(99)00092-3","article-title":"Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomised clinical trial in the Philippines","volume":"75","year":"2000","journal-title":"Acta Trop"},{"key":"key\n\t\t\t\t20180118035150_CIT0029","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/biol.1998.0156","article-title":"Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV)","volume":"26","year":"1998","journal-title":"Biologicals"},{"key":"key\n\t\t\t\t20180118035150_CIT0030","first-page":"655","article-title":"Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine","volume":"51","year":"2003","journal-title":"J Assoc Physicians India"},{"key":"key\n\t\t\t\t20180118035150_CIT0031","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/biol.1997.0117","article-title":"Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies","volume":"26","year":"1998","journal-title":"Biologicals"},{"key":"key\n\t\t\t\t20180118035150_CIT0032","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1016\/S0264-410X(01)00238-9","article-title":"Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine","volume":"19","year":"2001","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180118035150_CIT0033","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/infdis\/142.2.133","article-title":"Postexposure trial of a human diploid cell strain rabies vaccine","volume":"142","year":"1980","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180118035150_CIT0034","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/cid\/cis384","article-title":"Rabies postexposure prophylaxis in routine practice in view of the new Centers for Disease Control and Prevention and World Health Organization recommendations","volume":"55","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180118035150_CIT0035","first-page":"491","article-title":"Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group","volume":"76","year":"1998","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20180118035150_CIT0036","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.meegid.2015.09.024","article-title":"Phylogenetic analysis of Indian rabies virus isolates targeting the complete glycoprotein gene","volume":"36","year":"2015","journal-title":"Infect Genet Evol"},{"key":"key\n\t\t\t\t20180118035150_CIT0037","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.meegid.2014.07.014","article-title":"Rabies virus isolates of India\u2014simultaneous existence of two distinct evolutionary lineages","volume":"27","year":"2014","journal-title":"Infect Genet Evol"},{"key":"key\n\t\t\t\t20180118035150_CIT0038","first-page":"37","article-title":"Conservation of binding epitopes for monoclonal antibodies on the rabies virus glycoprotein","volume":"5","year":"2013","journal-title":"J Antivir Antiretrovir"},{"key":"key\n\t\t\t\t20180118035150_CIT0039","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/500470","article-title":"Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin","volume":"193","year":"2006","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180118035150_CIT0040","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1016\/S0264-410X(01)00135-9","article-title":"Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis","volume":"19","year":"2001","journal-title":"Vaccine"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/66\/3\/387\/23560229\/cix791.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T06:42:20Z","timestamp":1516257740000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/66\/3\/387\/4159363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,15]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,9,15]]},"published-print":{"date-parts":[[2018,1,18]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix791","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,2,1]]},"published":{"date-parts":[[2017,9,15]]}}}